Abstract Background & Aims Increases in mucosal immune cells have frequently been
observed in irritable bowel syndrome (IBS) patients. However, this finding is not completely …

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders,
characterized by abdominal pain, bloating, and changes in bowel habits. These symptoms …

Background A diet low in fermentable oligosaccharides, disaccharides, monosaccharides,
and polyols (FODMAP s) is increasingly recommended for patients with irritable bowel …

Background Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder of
unknown etiology; although infection and inflammation have recently been considered as …

Gastric cancer, one of the most common malignancies in the world, frequently reveals lymph
node, peritoneum, and liver metastases. Most of gastric cancer patients present with lymph …

The human gut is inhabited by diverse microorganisms that play crucial roles in health and
disease. Gut microbiota dysbiosis is increasingly considered as a vital factor in the …

OBJECTIVES: Evidence suggests that patients with irritable bowel syndrome (IBS) have an
altered cytokine profile, although it is unclear whether cytokines are linked with symptom …

Intestinal epithelial cells (IEC) are important parts of the mucosal barrier, whose function can
be impaired upon various injury factors such as lipopolysaccharide. Although food-derived …

Background & Aims In mice, activation of the transient receptor potential cation channels
(TRP) TRPV1, TRPV4, and TRPA1 causes visceral hypersensitivity. These receptors and …

Inflammatory bowel diseases (IBDs) are chronic immunological disorders of the intestinal
tract characterized by persistent inflammation. Baicalin, a type of flavonoid, has exhibited a …